Enhancing outcome prediction in patients with colorectal liver metastases undergoing hepatectomy: the synergistic impact of FIB-4 index and tumor burden score across KRAS profiles
HPB · 2025
DOI: 10.1016/j.hpb.2025.04.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift HPB, 2025. Verfasst von Miho Akabane und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, The Ohio State University, Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA. Hauptthemen laut MEDLINE: Hepatectomy, Colorectal Neoplasms, Liver Neoplasms, Proto-Oncogene Proteins p21(ras). Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: The prognostic value of Fibrosis-4 (FIB-4) index, concerning KRAS status (wild-type [wtKRAS] vs. mutated [mutKRAS]) remains unclear in post-hepatectomy colorectal liver metastases (CRLM). We evaluated the combined impact of FIB-4 and Tumor Burden Score (TBS) on overall survival (OS)/recurrence-free survival (RFS), stratified by KRAS status. METHODS: CRLM patients undergoing hepatectomy (2000-2020) were analyzed, grouped by TBS/FIB-4. RESULTS: Among 828 patients, 196 had high FIB-4. High TBS had worse 5-year OS (P < 0.001). In wtKRAS, high TBS correlated with worse OS (P < 0.001), but not in mutKRAS. High FIB-4 correlated with worse OS (P = 0.01). Sub-stratification showed no OS difference by FIB-4 in wtKRAS, but a difference in mutKRAS (P = 0.03). Multivariable analysis identified mutKRAS (HR: 1.90), high TBS (HR: 1.62), and FIB-4 (HR: 1.15) as mortality risk factors. The TBS-FIB-4-KRAS index had highest predictive accuracy. For RFS, TBS and FIB-4 independently stratified outcomes. High TBS was associated with worse RFS in wtKRAS (P < 0.001) but not in mutKRAS. High FIB-4 decreased RFS in mutKRAS (P = 0.001) but not in wtKRAS. FIB-4 was associated with a 10% increased recurrence risk. CONCLUSION: TBS and FIB-4, alongside KRAS status, should be considered to improve outcome predictions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Surgery, The Ohio State University, Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA.
- Department of General Surgery, Cleveland Clinic Foundation, OH, USA.
- Department of Surgery, Fundeni Clinical Institute, Bucharest, Romania.
- Department of Surgery, Keio University, Tokyo, Japan.
- Department of Surgery, Stanford University, Stanford, CA, USA.
- Department of Surgery, University of Verona, Italy.
Zitieren
APA
Akabane, M., Kawashima, J., Woldesenbetm, S., Macedo, A. B., Altaf, A., Aucejo, F., Popescu, I., Kitago, M., Poultsides, G. A., Sasaki, K., Imaoka, Y., Ruzzenente, A., Endo, I., & Pawlik, T. M. (2025). Enhancing outcome prediction in patients with colorectal liver metastases undergoing hepatectomy: the synergistic impact of FIB-4 index and tumor burden score across KRAS profiles. HPB. https://doi.org/10.1016/j.hpb.2025.04.002
Vancouver
Akabane M, Kawashima J, Woldesenbetm S, Macedo AB, Altaf A, Aucejo F, et al. Enhancing outcome prediction in patients with colorectal liver metastases undergoing hepatectomy: the synergistic impact of FIB-4 index and tumor burden score across KRAS profiles. HPB. 2025. doi:10.1016/j.hpb.2025.04.002
BibTeX
@article{Akabane2025,
author = {Akabane, Miho and Kawashima, Jun and Woldesenbetm, Selamawit and Macedo, Amanda B and Altaf, Abdullah and Aucejo, Federico and Popescu, Irinel and Kitago, Minoru and Poultsides, George A and Sasaki, Kazunari and Imaoka, Yuki and Ruzzenente, Andrea and Endo, Itaru and Pawlik, Timothy M},
title = {Enhancing outcome prediction in patients with colorectal liver metastases undergoing hepatectomy: the synergistic impact of FIB-4 index and tumor burden score across KRAS profiles},
journal = {HPB},
year = {2025},
doi = {10.1016/j.hpb.2025.04.002}
}
EUVIMED